yep sounds like we're basically in agreement.
I'm going to throw in a bit of speculation though, and bear in mind that this is the result of a bit of googling and no medical expertise. So take the following with a very large grain of salt.
The last line in the ann about FDA approval has a general comment about targeting "conditions where systemic LPS is believed to play a critical role". So when you google "systemic LPS" you get a bunch of links describing connections to neuroinflammation (eg Parkinson's disease).
Way back in the non-deal roadshow from March last year, the list of clinical programs includes a timeline for autism studies.
Now this is a world away from the NASH/ASH/NAFLD area. Is this idea of LPS/ neuroinflammation being linked still current or has it been discounted? Does the autism program have any momentum?
I don't want to go pushing a "magic pill" scenario but it interests me as to whether the idea of using IMM124 in neurological situations is vaguely plausible or not. My understanding is that the gut/brain thing is a trendy topic but I have no idea what the real hard science is and whether IMM124 is relevant.
But if HC is not for speculation then what is if for, that's what I say......
- Forums
- ASX - By Stock
- Ann: Immuron Aims to Secure FDA Approval for IMM-124E
yep sounds like we're basically in agreement. I'm going to throw...
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
8.2¢ |
Change
0.002(2.50%) |
Mkt cap ! $18.69M |
Open | High | Low | Value | Volume |
8.3¢ | 8.3¢ | 8.2¢ | $7.423K | 89.85K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50197 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 7694 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 68489 | 0.082 |
1 | 50000 | 0.080 |
3 | 42004 | 0.079 |
3 | 53820 | 0.078 |
1 | 60000 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 7694 | 1 |
0.087 | 12000 | 1 |
0.090 | 3100 | 1 |
0.094 | 164287 | 1 |
0.095 | 70000 | 1 |
Last trade - 15.54pm 03/07/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online